Scopio Labs, developer of Full-Field Digital Cell Morphology™ imaging and analysis platforms, as well as digital morphology, has been granted De Novo clearance by the U.S. Food and Drug Administration (FDA) for its Full-Field Bone Marrow Aspirate™ (FF-BMA) Application.